Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics
| Affiliates | Rituparna Bhattacharya [1], Raymond A Harvey [1], Keli Abraham [1], Jon Rosen [1], Paul Mehta [2]
[1] Humana Inc. |
| Journal | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration |
| Summary | This study estimates ALS prevalence and survival in participants with Medicare. The 5-year period prevalence was 20.5 per 100,000. The 2011-point prevalence for ALS was 11.8 per 100,000. Analyses using Medicare data resulted in higher ALS prevalence estimates than previously reported. |
| Link tp paper | Find the paper hereexternal icon! |
Page last reviewed: July 14, 2021
Content source: Agency for Toxic Substances and Disease Registry